Cargando…
Imbalance of Endocannabinoid/Lysophosphatidylinositol Receptors Marks the Severity of Alzheimer’s Disease in a Preclinical Model: A Therapeutic Opportunity
SIMPLE SUMMARY: Alzheimer’s disease (AD) remains a major challenge for the healthcare system worldwide and, to date, no curative treatment is available. This disease is an irreversible progressive dementia that harms memory and cognitive functions, weakening the ability to carry out tasks by themsel...
Autores principales: | Medina-Vera, Dina, Rosell-Valle, Cristina, López-Gambero, Antonio J., Navarro, Juan A., Zambrana-Infantes, Emma N., Rivera, Patricia, Santín, Luis J., Suarez, Juan, Rodríguez de Fonseca, Fernando |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7694492/ https://www.ncbi.nlm.nih.gov/pubmed/33167441 http://dx.doi.org/10.3390/biology9110377 |
Ejemplares similares
-
A Negative Energy Balance Is Associated with Metabolic Dysfunctions in the Hypothalamus of a Humanized Preclinical Model of Alzheimer’s Disease, the 5XFAD Mouse
por: López-Gambero, Antonio J., et al.
Publicado: (2021) -
Lysophosphatidylinositol Signalling and Metabolic Diseases
por: Arifin, Syamsul A., et al.
Publicado: (2016) -
d‐Pinitol promotes tau dephosphorylation through a cyclin‐dependent kinase 5 regulation mechanism: A new potential approach for tauopathies?
por: Medina‐Vera, Dina, et al.
Publicado: (2022) -
The Expression of the Endocannabinoid Receptors CB2 and GPR55 Is Highly Increased during the Progression of Alzheimer’s Disease in App(NL-G-F) Knock-In Mice
por: Medina-Vera, Dina, et al.
Publicado: (2023) -
Peptide targeting of lysophosphatidylinositol-sensing GPR55 for osteoclastogenesis tuning
por: Mosca, Maria Giovanna, et al.
Publicado: (2021)